Keloid Treatment Market: By Type, By End User and Region Forecast 2019-2030

Keloid Treatment Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Compression Therapy, Intralesional Corticosteroid Injections, Occlusive Dressing, Excision, Cryosurgery, Laser Therapy, Radiation Therapy, Interferon Therapy), By End User (Hospitals, Beauty Centres, Dermatology Clinics, Others) and Region Forecast 2019-2030

Keloid Treatment Market size was valued at US$ 3620 million in 2023 and is poised to grow at a CAGR of 5.8% from 2024-2030. A keloid is an overgrown scar that rises beyond the skin's surface as a result of the creation of extra scar tissue on the healed skin area following surgery, a burn, or an injury. Keloids are most commonly found on the hands, legs, and neck, but they can appear anywhere. Although the exact cause of keloids is unknown, numerous factors such as age, gender, blood group, type of lesion, anatomical site, number of sites wounded, and family history can all play a role in identifying the cause. Other factors that may contribute to keloid formation and in predicting keloid behaviour during diagnosis or therapy include delayed wound healing and hypertension. Excess of a protein in ones skin during cure process after an injury causes raised scar, which is known as keloid.

Keloid treatment greatly helps to flatten, soften and north america stretch and shrink film the keloid as they are tough to get rid of entirely. Healthcare experts generally give combination treatment for obtaining high treatment efficiency rates. Keloid scar can reduce over a period. Keloid scars are generally found in people of age group 10-30 years Keloid scar cases are hugely seen in Asian, African as well as American People. Acquisitions, mergers, collaborations and new product introduction are some of the effective strategies followed by the industries of the market in order to strengthen their place in the market.  Key players of this market are also bringing new technologies in the market. An abnormal proliferation of a scar tissue which farms at site of cutaneous injury is called as keloid. Keloid scar doesnt regress and progress beyond the scars original margin and it can reduce over a period of time. Keloids are the benign fibroproliferative dermal tumours.  

Key Developments

  • For Instance, Lumenis acquired An Israel aesthetic company named Pollogen Ltd for expanding its product portfolio in the year 2015.

Keloid Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

5.8%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Keloid Treatment Market Dynamics

Adoption of technological advancements in derma care, increase in awareness among the people regarding treatment for the keloids expected to fuel the market. Furthermore, lifestyle changes, growing beauty consciousness, rise in personal care expenditure, growing acceptance of the patients to various treatment approaches are the factors which are expected to boost the growth of the market.

However, lack of awareness, adverse effects regarding the treatment, high cost of treatment are major restraints of the market. As per National Institute of Health, Keloid scars are most common in people with age group of 10-30 years. Keloid scars are commonly seen in African Americans, Asians, or Hispanic descents. Growing consciousness regarding appearance and looks among people is the major driving factor for the market.

Keloid Treatment Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 3620 million

Market CAGR

5.8%

By Type

  • Compression Therapy
  • Intralesional Corticosteroid Injections
  • Occlusive Dressing
  • Excision
  • Cryosurgery
  • Laser Therapy
  • Radiation Therapy
  • Interferon Therapy

By End User

  • Hospitals
  • Beauty Centres
  • Dermatology Clinics
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The keloid treatment market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The global keloid treatment market size was valued at US$ 3620 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.

Growing Concerns Regarding Aesthetics Appearances

Asia Pacific is the fastest-growing for the market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Keloid Treatment Market Introduction 
2.1.Global Keloid Treatment Market  - Taxonomy
2.2.Global Keloid Treatment Market  - Definitions
2.2.1.Type
2.2.2.End User
2.2.3.Region
3. Global Keloid Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Keloid Treatment Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Keloid Treatment Market  By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Compression Therapy
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Intralesional Corticosteroid Injections
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Occlusive Dressing
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Excision
5.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Cryosurgery
5.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Laser Therapy
5.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Radiation Therapy
5.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Interferon Therapy
5.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
6. Global Keloid Treatment Market  By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Beauty Centres
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Dermatology Clinics
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Keloid Treatment Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. North America Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Compression Therapy
8.1.2.Intralesional Corticosteroid Injections
8.1.3.Occlusive Dressing
8.1.4.Excision
8.1.5.Cryosurgery
8.1.6.Laser Therapy
8.1.7.Radiation Therapy
8.1.8.Interferon Therapy
8.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Beauty Centres
8.2.3.Dermatology Clinics
8.2.4.Others
8.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9. Europe Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Compression Therapy
9.1.2.Intralesional Corticosteroid Injections
9.1.3.Occlusive Dressing
9.1.4.Excision
9.1.5.Cryosurgery
9.1.6.Laser Therapy
9.1.7.Radiation Therapy
9.1.8.Interferon Therapy
9.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Beauty Centres
9.2.3.Dermatology Clinics
9.2.4.Others
9.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
9.3.7.
10. Asia Pacific (APAC) Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Compression Therapy
10.1.2.Intralesional Corticosteroid Injections
10.1.3.Occlusive Dressing
10.1.4.Excision
10.1.5.Cryosurgery
10.1.6.Laser Therapy
10.1.7.Radiation Therapy
10.1.8.Interferon Therapy
10.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Beauty Centres
10.2.3.Dermatology Clinics
10.2.4.Others
10.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11. Middle East and Africa (MEA) Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Compression Therapy
11.1.2.Intralesional Corticosteroid Injections
11.1.3.Occlusive Dressing
11.1.4.Excision
11.1.5.Cryosurgery
11.1.6.Laser Therapy
11.1.7.Radiation Therapy
11.1.8.Interferon Therapy
11.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Beauty Centres
11.2.3.Dermatology Clinics
11.2.4.Others
11.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12. Latin America Keloid Treatment Market, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Compression Therapy
12.1.2.Intralesional Corticosteroid Injections
12.1.3.Occlusive Dressing
12.1.4.Excision
12.1.5.Cryosurgery
12.1.6.Laser Therapy
12.1.7.Radiation Therapy
12.1.8.Interferon Therapy
12.2.  End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Beauty Centres
12.2.3.Dermatology Clinics
12.2.4.Others
12.3.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.GlaxoSmithKline Plc
13.2.2.Avita Medical
13.2.3.Pacific World Corporation
13.2.4.Bristol-Myers Squibb Company
13.2.5.Renovo Group plc
13.2.6.Novartis AG
13.2.7.Valeant Pharmaceuticals International Inc
13.2.8.RXi Pharmaceuticals
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • GlaxoSmithKline Plc
  • Avita Medical
  • Pacific World Corporation
  • Bristol-Myers Squibb Company
  • Renovo Group plc
  • Novartis AG
  • Valeant Pharmaceuticals International Inc
  • RXi Pharmaceuticals
  • Galena Biopharma

Related Industry Reports